Immix Biopharma, INC. (IMMX) SEC Filings — 2025

Filings

• Immix Biopharma, INC. 8-K Filing — 8-K · Dec 8, 2025
• Immix Biopharma Files 8-K: Corporate Details Updated — 8-K · Nov 26, 2025
• Immix Biopharma's Losses Widen Amid Rising R&D Costs — 10-Q · Nov 7, 2025
• Immix Biopharma Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Sep 8, 2025
• Immix Biopharma's Q2 Loss Widens Amid R&D Spend — 10-Q · Aug 8, 2025
• Immix Biopharma Reports on Shareholder Vote — 8-K · Jun 23, 2025
• Immix Biopharma Files 8-K: Material Agreement & Exhibits — 8-K · Jun 3, 2025
• Immix Biopharma Files 2024 Annual Report Amendment — 10-K/A · May 19, 2025
• Immix Biopharma Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Immix Biopharma Sets June 20th Annual Meeting — DEFA14A · May 5, 2025
• Immix Biopharma Files Definitive Proxy Statement — DEF 14A · Apr 30, 2025
• Immix Biopharma, INC. 10-K Filing — 10-K · Mar 25, 2025